BC
SANA icon

Bartlett & Co’s Sana Biotechnology SANA Stock Holding History

Bartlett & Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$0 Hold
100
– – ﹤0.01% 1245
2023
Q3 		$0 Hold
100
– – ﹤0.01% 1174
2023
Q2 		$1K Hold
100
– – ﹤0.01% 1106
2023
Q1 		$0 Hold
100
– – ﹤0.01% 1085
2022
Q4 		$0 Hold
100
– – ﹤0.01% 1165
2022
Q3 		$1K Hold
100
– – ﹤0.01% 1123
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1247
2022
Q1 		$1K Buy
+100
New +$809 ﹤0.01% 1034

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Bartlett & Co's SANA Position: Q4 2023 in Review

Bartlett & Co held its Sana Biotechnology (SANA) position steady in Q4 2023 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Bartlett & Co first reported a position in SANA in Q1 2022 and has held it in 8 quarters since. The position peaked at $1K in Q2 2023. 132 funds tracked by Wall St. Rank hold SANA as of Q4 2023.

  • Bartlett & Co held 100 shares of Sana Biotechnology worth $0 as of Q4 2023.
  • Bartlett & Co left its Sana Biotechnology share count unchanged in Q4 2023.
  • Sana Biotechnology made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1245 holding.
  • Bartlett & Co first reported a position in Sana Biotechnology in Q1 2022 and has held it in 8 quarters since.
  • Bartlett & Co's Sana Biotechnology position peaked at $1K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.